Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Brodiaea orcuttii

ABSTRACT: Brodiaea orcutti Genome sequencing and assembly

PROVIDER: PRJNA1086974 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28321254_1.fastq.gz	Fastqsanger.gz
	SRR28321254_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Brodiaea pallida

Project description:Brodiaea pallida Genome sequencing and assembly

| PRJNA1197549 | ENA

Brodiaea kinkiensis

Project description:Brodiaea kinkiensis Genome sequencing and assembly

| PRJNA1402065 | ENA

Brodiaea filifolia

Project description:Brodiaea filifolia sequencing and assembly

| PRJNA1085364 | ENA

Brodiaea californica subsp. leptandra

Project description:Brodiaea californica subsp. leptandra Genome sequencing and assembly

| PRJNA1402057 | ENA

Gila orcuttii

Project description:Gila orcuttii alternate pseudohaplotype genome sequencing

| PRJNA896188 | ENA

Gila orcuttii

Project description:Gila orcuttii principal pseudohaplotype genome sequencing

| PRJNA896189 | ENA

Gila orcuttii

Project description:Gila orcuttii Whole Genome Resequencing

| PRJNA1017891 | ENA

Project description:Radseq data for Brodiaea filifolia and Brodiaea santarosae

| PRJNA1427302 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Gila orcuttii

Project description:Gila orcuttii overview

| PRJNA896313 | ENA